JP2004519440A5 - - Google Patents

Download PDF

Info

Publication number
JP2004519440A5
JP2004519440A5 JP2002550986A JP2002550986A JP2004519440A5 JP 2004519440 A5 JP2004519440 A5 JP 2004519440A5 JP 2002550986 A JP2002550986 A JP 2002550986A JP 2002550986 A JP2002550986 A JP 2002550986A JP 2004519440 A5 JP2004519440 A5 JP 2004519440A5
Authority
JP
Japan
Prior art keywords
core
benazepril
pharmaceutically acceptable
pharmaceutical composition
amlodipine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002550986A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004519440A (ja
Filing date
Publication date
Priority claimed from PCT/US2000/034246 external-priority patent/WO2002049645A1/en
Application filed filed Critical
Publication of JP2004519440A publication Critical patent/JP2004519440A/ja
Publication of JP2004519440A5 publication Critical patent/JP2004519440A5/ja
Withdrawn legal-status Critical Current

Links

JP2002550986A 2000-12-18 2001-12-17 アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ Withdrawn JP2004519440A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2000/034246 WO2002049645A1 (en) 2000-12-18 2000-12-18 Therapeutic combination of amlodipine and benazepril
PCT/US2001/048808 WO2002049646A1 (en) 2000-12-18 2001-12-17 Therapeutic combination of amlodipine and benazepril/benazeprilat

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009235225A Division JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ

Publications (2)

Publication Number Publication Date
JP2004519440A JP2004519440A (ja) 2004-07-02
JP2004519440A5 true JP2004519440A5 (cg-RX-API-DMAC10.html) 2005-12-22

Family

ID=21742073

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002550985A Pending JP2004516266A (ja) 2000-12-18 2000-12-18 アムロジピンおよびベナゼブリルの治療的組み合わせ
JP2002550986A Withdrawn JP2004519440A (ja) 2000-12-18 2001-12-17 アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ
JP2009235225A Pending JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002550985A Pending JP2004516266A (ja) 2000-12-18 2000-12-18 アムロジピンおよびベナゼブリルの治療的組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009235225A Pending JP2010043111A (ja) 2000-12-18 2009-10-09 アムロジピンとベナゼプリル/ベナゼプリラートの治療上の組み合せ

Country Status (26)

Country Link
EP (3) EP1365761A1 (cg-RX-API-DMAC10.html)
JP (3) JP2004516266A (cg-RX-API-DMAC10.html)
KR (3) KR20040007420A (cg-RX-API-DMAC10.html)
CN (2) CN1461218A (cg-RX-API-DMAC10.html)
AT (1) ATE338549T1 (cg-RX-API-DMAC10.html)
AU (4) AU2001225816B2 (cg-RX-API-DMAC10.html)
BR (2) BR0017386A (cg-RX-API-DMAC10.html)
CA (2) CA2432638A1 (cg-RX-API-DMAC10.html)
CY (1) CY1106275T1 (cg-RX-API-DMAC10.html)
CZ (2) CZ20031678A3 (cg-RX-API-DMAC10.html)
DE (1) DE60122928T2 (cg-RX-API-DMAC10.html)
DK (1) DK1345607T3 (cg-RX-API-DMAC10.html)
EC (1) ECSP034658A (cg-RX-API-DMAC10.html)
ES (1) ES2272565T3 (cg-RX-API-DMAC10.html)
HU (2) HUP0302455A3 (cg-RX-API-DMAC10.html)
IL (4) IL156136A0 (cg-RX-API-DMAC10.html)
MX (2) MXPA03005462A (cg-RX-API-DMAC10.html)
NO (2) NO20032766L (cg-RX-API-DMAC10.html)
NZ (1) NZ526467A (cg-RX-API-DMAC10.html)
PL (2) PL362252A1 (cg-RX-API-DMAC10.html)
PT (1) PT1345607E (cg-RX-API-DMAC10.html)
RU (1) RU2292206C2 (cg-RX-API-DMAC10.html)
SI (1) SI1345607T1 (cg-RX-API-DMAC10.html)
SK (2) SK7652003A3 (cg-RX-API-DMAC10.html)
WO (2) WO2002049645A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200304514B (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0214383A (pt) * 2001-11-23 2004-11-03 Solvay Pharm Gmbh Tratamento de hipertonia durante a fase aguda do ataque de apoplexia
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
CN1859913A (zh) 2003-04-25 2006-11-08 美国诺华卡迪亚公司 改善肾功能损伤个体多尿症的方法
KR20060120126A (ko) * 2003-10-20 2006-11-24 노파르티스 아게 심혈관계 이환상태를 감소시키기 위한 베나제프릴 및암로디핀
WO2005074927A1 (en) * 2004-02-09 2005-08-18 Novartis Ag Therapeutic combination of amlodipine and benazepril/ benazeprilat for the treatment of hypertension
WO2005079772A2 (en) * 2004-02-18 2005-09-01 Sepracor Inc. Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US20080268049A1 (en) * 2005-02-11 2008-10-30 Dhaliwal Mona Stable Solid Dosage Forms of Amlodipine and Benazepril
WO2006092732A2 (en) * 2005-03-04 2006-09-08 Aurobindo Pharma Ltd Stable solid dosage form of antihypertensive agent
MX2007011119A (es) 2005-03-15 2007-11-14 Lupin Ltd Composiciones farmaceuticas de amlodipino y benazepril.
EP1930008A1 (en) * 2005-09-28 2008-06-11 Teva Pharmaceutical Industries Ltd Sable composition of benazepril hydrochloride
US8158146B2 (en) 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
JP2009508948A (ja) * 2005-09-28 2009-03-05 テバ ファーマシューティカル インダストリーズ リミティド アムロジピンベシレート及びベナゼプリル塩酸塩の安定した組合わせ
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
IT1398168B1 (it) * 2010-02-16 2013-02-14 Chiesi Farma Spa Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
CN102389431A (zh) * 2011-09-28 2012-03-28 济南龙华医药技术有限公司 一种含有盐酸贝尼地平和盐酸贝那普利的复方制剂及其应用
RU2014129508A (ru) * 2011-12-21 2016-02-10 Новартис Тиргезундхайт АГ Новая комбинация
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
JP2015529206A (ja) * 2012-08-25 2015-10-05 ザ・ジョンズ・ホプキンス・ユニバーシティ Gapdhカスケードインヒビター化合物ならびに使用の方法および精神病を含むストレス誘導障害の処置
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
MX375936B (es) 2013-12-04 2025-03-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmaceuticas mejoradas de pimobendan.
EP3434284A4 (en) * 2016-03-24 2019-11-13 Daiichi Sankyo Company, Limited MEDICINE FOR THE TREATMENT OF KIDNEY DISEASE
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
PL3541807T3 (pl) 2016-11-16 2022-01-17 H. Lundbeck A/S Krystaliczna postać inhibitora magl
CA3043609A1 (en) 2016-11-16 2018-05-24 Abide Therapeutics, Inc. Pharmaceutical formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
EP0804229B1 (en) * 1995-03-16 2003-03-26 Pfizer Inc. Use of amlodipine, a salt thereof or felodipin in combination with an ace inhibitor in the manufacture of a medicament for the treatment of nonischemic congestive heart failure
KR19980703647A (ko) * 1995-04-07 1998-12-05 베르너발데크 베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Similar Documents

Publication Publication Date Title
RU2003121019A (ru) Терапевтическая композиция амлодипина и беназеприла/беназеприлата
JP4995912B2 (ja) アムロジピン及びロサルタンを含む薬剤学的組成物
ES2380704T3 (es) Metanosulfonato de éster etílico de ácido 3-[(2-{[4-(hexiloxicarbonilamino--imino-metil)-fenilamino]-metil}-1-metil-1H-bencimidazol-5-carb3onil)-piridin-2-il-amino]-propiónico
JP5162689B2 (ja) 活性成分としてのパントプラゾールを含有する投与形
US20050163847A1 (en) Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
KR101875112B1 (ko) 암로디핀, 발사르탄 및 로수바스타틴을 포함하는 약학적 조성물
CZ274897A3 (cs) Orální farmaceutické lékové formy obsahující inhibitor protonové pumpy a NSAID
TWI388316B (zh) 抑制胃酸分泌之組合物及方法
WO2009127974A2 (ko) 심혈관계 질환 치료용 약제학적 제제
JP7482182B2 (ja) プロトンポンプ阻害剤を含む経口用固形製剤組成物、それを含む経口用固形製剤及びその製造方法
KR101171375B1 (ko) 난용성 약물을 함유하는 경구 제형
EA030704B1 (ru) Фармацевтическая композиция, содержащая кандесартана цилексетил и амлодипин
KR102369607B1 (ko) 암로디핀 및 로잘탄을 포함하는 고형 약제학적 조성물
RU2012112051A (ru) Препараты ингибиторы тромбообразования
WO2013013351A1 (zh) 复方甲氧那明的速释-缓释渗透泵制剂
JP2024500545A5 (cg-RX-API-DMAC10.html)
TW202103697A (zh) 包含依澤替米貝(ezetimibe)及洛沙坦(losartan)之藥學組合製劑
EA032808B1 (ru) Дозированная лекарственная форма, содержащая бисопролол и периндоприл
CA2620018A1 (en) Stable combinations of amlodipine besylate and benazepril hydrochloride
KR102882732B1 (ko) 고혈압 치료용 복합 약제학적 조성물
TWI734046B (zh) 包含替米沙坦或其藥學上可接受鹽類之具有改良的吸濕性質和溶解速率之製劑
KR20110031226A (ko) 에프로사르탄 조성물
CN101272791A (zh) 苯磺酸氨氯地平和盐酸贝那普利的稳定的组合
KR20090107961A (ko) 심혈관계 질환 치료용 약제학적 제제
WO2014122585A1 (en) A stable pharmaceutical composition of amlodipine and benazepril or salts thereof